Live from the NIH registry
Studies recruiting near Waco right now
Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - Central/South Texas — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Computerized Depression Intervention in Veterans
Depression
N/A
Interventional 152 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Waco Cardiology — Waco, Texas (2.6 mi)
· Sponsor: Alleviant Medical, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NextStage Clinical Research — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Velocity Clinical Research — Waco, Texas (2.6 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Phase 3
Interventional 1,205 participants sought
NextStage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Eli Lilly and Company
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Texas Oncology - Waco — Waco, Texas (2.6 mi)
· Sponsor: Agendia
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary Cholangitis, PBC
Phase 2
Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi)
· Sponsor: Mirum Pharmaceuticals, Inc.
National Sponsorship Program for Transitioning Service Members
Reintegration Difficulties, Health
N/A
Interventional 630 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 400 participants sought
Digestive Research of Central Texas, LLC — Waco, Texas (2.6 mi)
· Sponsor: Takeda
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Central/South Texas — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Woodway, Texas (3.9 mi)
· Sponsor: AstraZeneca
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Digestive Research of Central Texas — Waco, Texas (2.6 mi)
· Sponsor: Eccogene
Paper-Based and Smartphone-Based Memory Supports
Alzheimer Disease, Dementia, Mild
N/A
Interventional 200 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
Reliability and Validity of the PReFS
Neurologic Disorders, Spinal Cord Injury
N/A
Observational 15 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: AstraZeneca